Socioeconomic disadvantage and kidney disease in the United States, Australia, and Thailand

American Journal of Public Health

Volumn 98, Issue 7, 2008, Pages 1306-1313

  White, Sarah L ^a,b   McGeechan, Kevin ^c   Jones, Michael ^g   Cass, Alan ^a,b   Chadban, Steven J ^b,d   Polkinghorne, Kevan R ^e   Perkovic, Vlado ^a,b   Roderick, Paul J ^f  

^a King George V Building   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^e MONASH MEDICAL CENTRE   (Australia)

^f UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^g NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; AUSTRALIA; CAUCASIAN; CHRONIC KIDNEY DISEASE; EDUCATION; FEMALE; HISPANIC; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SOCIOECONOMICS; THAILAND; UNITED STATES; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; HOSPITALIZATION; MINORITY GROUP; MULTIVARIATE ANALYSIS; PATIENT; POVERTY; PRIMARY PREVENTION; RISK; STATISTICS;

AUSTRALIA; CONFIDENCE INTERVALS; KIDNEY FAILURE, CHRONIC; MEDICALLY UNINSURED; MINORITY GROUPS; MULTIVARIATE ANALYSIS; ODDS RATIO; POVERTY; PREVALENCE; PRIMARY PREVENTION; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS; THAILAND; UNITED STATES;

EID: 45549101272     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2007.116020     Document Type: Article

References (43)

1. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med. 1998;339:1448-1456.
2. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164:659-663.
3. Johnson DW. Evidence-based guide to slowing the progression of early renal insufficiency. Intern Med J. 2004;34:50-57.
4. Kunst AE, Groenhof F, Mackenbach JP, Health EW. Occupational class and cause specific mortality in middle aged men in 11 European countries: comparison of population based studies. EU Working Group on Socioeconomic Inequalities in Health. BMJ. 1998;316:1636-1642.
5. Lynch JW, Kaplan GA, Cohen RD, Tuomilehto J, Salonen JT. Do cardiovascular risk factors explain the relation between socioeconomic status, risk of all-cause mortality, cardiovascular mortality, and acute myocardial infarction? Am J Epidemiol. 1996;144:934-942.
6. van Rossum CT, Shipley MJ, van de Mheen H, Grobbee DE, Marmot MG. Employment grade differences in cause specific mortality. A 25-year follow up of civil servants from the first Whitehall study. J Epidemiol Community Health. 2000;54:178-184.
7. Fored CM, Ejerblad E, Fryzek JP, et al. Socioeconomic status and chronic renal failure: a population-based case-control study in Sweden. Nephrol Dial Transplant. 2003;18:82-88.
8. Merkin SS, Coresh J, Roux AV, Taylor HA, Powe NR. Area socioeconomic status and progressive chronic kidney disease: the Atherosclerosis Risk in Communities (ARIC) study. Am J Kidney Dis. 2005;46:203-213.
9. Martins D, Tareen N, Zadshir A, et al. The association of poverty with the prevalence of albuminuria: data from the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis. 2006;47:965-971.
10. Drey N, Roderick P, Mullee M, Rogerson M. A population-based study of the incidence and outcomes of diagnosed chronic kidney disease. Am J Kidney Dis. 2003;42:677-684.
11. Barsoum R. End-stage renal disease in North Africa. Kidney Int Suppl. 2003;63(suppl 83):S111-S114.
12. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001;104:2746-2753.
13. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures. Vital Health Stat 1. 1994;32:1-407.
14. InterASIA Collaborative Group. Cardiovascular risk factor levels in urban and rural Thailand - The International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Eur J Cardiovasc Prev Rehabil. 2003;10:249-257.
15. Dunstan DW, Zimmet PZ, Welborn TA, et al. The Australian Diabetes, Obesity and Lifestyle Study (Aus-Diab) - methods and response rates. Diabetes Res Clin Pract. 2002;57:119-129.
16. Dirks JH, de Zeeuw D, Agarwal SK, et al. Prevention of chronic kidney and vascular disease: toward global health equity - the Bellagio 2004 Declaration. Kidney Int Suppl. 2005;68(suppl 98):S1-S6.
17. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1-12.
18. United States Renal Data System, USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; 2006.
19. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 suppl 1):S1-S266.
20. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-470.
21. Levey AS, Greene T, Kusek JW, Beck GJ, Group MS. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 2000;11:A0828.
22. Chadban SJ, Briganti EM, Kerr PG, et al. Prevalence of kidney damage in Australian adults: the Aus-Diab kidney study. J Am Soc Nephrol. 2003;14(suppl 2):S131-S138.
23. Coresh J, Astor BC, McQuillan G, et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis. 2002;39:920-929.
24. Förster MF, Mira d'Ercole M. Income Distribution and Poverty in OECD Countries in the Second Half of the 1990s. Paris, France: Organisation for Economic Co-operation and Development; 2005. OECD Social, Employment and Migration Working Paper, No. 22.
25. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA. 2004;291:844-850.
26. Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med. 1999;341:1127-1133.
27. Banks J, Marmot M, Oldfield Z, Smith JP. Disease and disadvantage in the United States and in England. JAMA. 2006;295:2037-2045.
28. Levin A, Stevens L, McCullough PA. Cardiovascular disease and the kidney. Tracking a killer in chronic kidney disease. Postgrad Med. 2002;111:53-60.
29. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006;23:469-480.
30. The World Bank Group. Education Attainment in the Adult Population (Barro-Lee Dataset). Available at: http://go.worldbank.org/5Y76FNJ0I0. Accessed December 1, 2006.
31. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluations, classifications, and stratification. Ann Intern Med. 2003;139:137-147.
32. Marmot MG, Smith GD, Stansfeld S, et al. Health inequalities among British civil servants: the Whitehall II study. Lancet. 1991;337:1387-1393.
33. Brenner BM, Chertow GM. Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. Am J Kidney Dis. 1994;23:171-175.
34. Popkin BM. Urbanization, lifestyle changes and the nutrition transition. World Dev. 1999;27:1905-1916.
35. World Health Organization. The World Health Report 2002. Geneva, Switzerland: World Health Organization; 2002.
36. Sitprija V. Nephrology in South East Asia: fact and concept. Kidney Int Suppl. 2003;63(suppl 83):S128-S130.
37. Shoham DA, Vupputuri S, Kshirsagar AV. Chronic kidney disease and life course socioeconomic status: a review. Adv Chronic Kidney Dis. 2005;12:56-63.
38. Zuo L, Ma YC, Zhou YH, Wang M, Xu GB, Wang HY. Application of GFR-estimating equations in Chinese patients with chronic kidney disease. Am J Kidney Dis. 2005;45:463-472.
39. Young EW, Mauger EA, Jiang KH, Port FK, Wolfe RA. Socioeconomic status and end-stage renal disease in the United States. Kidney Int. 1994;45:907-911.
40. Byrne C, Nedelman J, Luke RG. Race, socioeconomic status, and the development of end-stage renal disease. Am J Kidney Dis. 1994;23:16-22.
41. Cass A, Cunningham J, Wang Z, Hoy W. Social disadvantage and variation in the incidence of endstage renal disease in Australian capital cities. Aust N Z J Public Health. 2001;25:322-326.
42. Perneger TV, Whelton PK, Klag MJ. Race and end-stage renal disease. Socioeconomic status and access to health care as mediating factors. Arch Intern Med. 1995;155:1201-1208.
43. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296-1305.